Baseline characteristics of the patients (n=54)
| Male : female | 14 : 40 |
|---|---|
| Age (y (range)) | 56.09 (24–78) |
| Mean Tsui score at inclusion (SD) | 8.98 (3.3) |
| Mean duration of disease (y (range)) | 13 (2–45) |
| Mean number of preprotocol injections (range) | 17.5 (4–30) |
| Mean time between the last preprotocol injection and inclusion in days (range) | 128.5 (91–210) |
| Mean total dose injected in the 2 last preprotocol injections in Botox units (range, SD) | 104.44 (70–180, 20.6) |
| Concomitant treatments (number of patients): | |
| Benzodiazepines | 22 |
| Anticholinergics | 29 |
| Myorelaxants | 30 |